<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37053048</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Clinicopathologic features in childhood-onset lupus nephritis with antineutrophil cytoplasmic antibody positivity--a multi-center retrospective study.</ArticleTitle><Pagination><StartPage>791</StartPage><EndPage>798</EndPage><MedlinePgn>791-798</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231171288</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Positive antineutrophil cytoplasmic antibody (ANCA) serology in adult-onset lupus nephritis (LN) is associated with more active disease and distinct renal pathology, but data with respect to childhood-onset LN remain scarce. Here, we aimed to determine the impact of positive ANCA serology on clinical and histopathologic features and renal outcomes in children with LN from multiple centers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Clinical and histopathologic data of 61 ANCA-positive and 330 ANCA-negative LN children (1&lt;age&#x2264;18&#xa0;years) retrospectively enrolled from three pediatric nephrology centers were analyzed. Among them, 217 children were followed and survival analysis was performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 61 ANCA-positive LN children, 86.9% of them had antimyeloperoxidase antibodies. Both ANCA-positive and ANCA-negative children had high disease activities with median SLEDAI-2K of 16 (13, 20). Hematuria was more prominent (urinary RBC +++ &#x223c; ++++: 45.9% vs 26.7%, <i>p</i> = 0.011), while fever (42.6% vs. 58.2%, <i>p</i> = 0.035), alopecia (3.3% vs. 14.5%, <i>p</i> = 0.019), photosensitivity (0% vs. 8.2%, <i>p</i> = 0.013), and pleurisy (4.9% vs. 15.8%, <i>p</i> = 0.026) were less common in ANCA-positive children. Higher proportions of segmental sclerosis (23.7% vs. 9.8%, <i>p</i> = 0.025), crescentic formation (36.4% vs. 16.3%, <i>p</i> = 0.009), and capillary wall thickening (24.5% vs. 11.0%, <i>p</i> = 0.01) were observed in biopsies of ANCA-positive children. Long-term renal survival did not differ significantly between two groups (<i>p</i> = 0.300).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Positive ANCA serology in LN children was associated with different clinical and histopathologic features compared to those with negative ANCA serology. Further studies are needed to clarify the pathogenic role of ANCAs in childhood-onset LN and confirm their association with prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Bei</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-9547-7757</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology and Nephrology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation><Identifier Source="RINGGOLD">71068</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology and Nephrology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation><Identifier Source="RINGGOLD">71068</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Meizhen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangzhou Women and Children's Medical Center, Guangzhou, China.</Affiliation><Identifier Source="RINGGOLD">159390</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology and Immunology, Fujian Children's Hospital, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lizhi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology and Nephrology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation><Identifier Source="RINGGOLD">71068</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhilang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology and Nephrology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation><Identifier Source="RINGGOLD">71068</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Shuhan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology and Nephrology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation><Identifier Source="RINGGOLD">71068</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zihua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology and Immunology, Fujian Children's Hospital, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yingjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangzhou Women and Children's Medical Center, Guangzhou, China.</Affiliation><Identifier Source="RINGGOLD">159390</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xiaoyun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology and Nephrology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation><Identifier Source="RINGGOLD">71068</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019268">Antibodies, Antineutrophil Cytoplasmic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019268" MajorTopicYN="N">Antibodies, Antineutrophil Cytoplasmic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006417" MajorTopicYN="N">Hematuria</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antineutrophil cytoplasmic antibody</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">clinicopathologic features</Keyword><Keyword MajorTopicYN="N">lupus nephritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37053048</ArticleId><ArticleId IdType="doi">10.1177/09612033231171288</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>